Inflammatory bowel disease: A systematic review on the value of diagnostic testing in primary care

Colorectal Disease

Volumn 13, Issue 3, 2011, Pages 239-254

  Jellema, P ^a   Van Tulder, M W ^b   Van Der Horst, H E ^a   Florie, J ^c   Mulder, C J ^a   Van Der Windt, D A W M ^a,d  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d KEELE UNIVERSITY   (United Kingdom)

Author keywords

Diagnosis; Inflammatory bowel disease; Primary care; Systematic review

Indexed keywords

CALGRANULIN;

BLOOD ANALYSIS; CLINICAL ASSESSMENT; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; ECHOGRAPHY; ENTERITIS; FECES ANALYSIS; HUMAN; MEDICAL DECISION MAKING; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SYMPTOM; SYSTEMATIC REVIEW;

FECES; HUMANS; INFLAMMATORY BOWEL DISEASES; LEUKOCYTE L1 ANTIGEN COMPLEX; PRIMARY HEALTH CARE; SENSITIVITY AND SPECIFICITY;

EID: 79951527952     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2009.02131.x     Document Type: Review

References (53)

1. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004; 126: 1504-17.
2. Lasson A, Kilander A, Stotzer PO. Diagnostic yield of colonoscopy based on symptoms. Scand J Gastroenterol 2008; 43: 356-62.
3. Bernklev T, Jahnsen J, Lygren I, Henriksen M, Vatn M, Moum B. Health-related quality of life in patients with inflammatory bowel disease measured with the short form-36: psychometric assessments and a comparison with general population norms. Inflamm Bowel Dis 2005; 11: 909-18.
4. Eaden J. Review article: colorectal carcinoma and inflammatory bowel disease. Aliment Pharmacol Ther 2004; 20(Suppl. 4): 24-30.
5. Stange EF, Travis SP, Vermeire S et al. European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut 2006; 55(Suppl. 1): i1-15.
6. Sands BE. From symptom to diagnosis: clinical distinctions among various forms of intestinal inflammation. Gastroenterology 2004; 126: 1518-32.
7. Hommes DW, van Deventer SJ. Endoscopy in inflammatory bowel diseases. Gastroenterology 2004; 126: 1561-73.
8. Muris JW, Starmans R, Fijten GH, Crebolder HF, Schouten HJ, Knottnerus JA. Non-acute abdominal complaints in general practice: diagnostic value of signs and symptoms. Br J Gen Pract 1995; 45: 313-6.
9. Ellis BG, Thompson MR. Factors identifying higher risk rectal bleeding in general practice. Br J Gen Pract 2005; 55: 949-55.
10. Robertson R, Campbell C, Weller DP, Elton R, Mant D, Primrose J, Nugent K, Macleod U, Sharma R. Predicting colorectal cancer risk in patients with rectal bleeding. Br J Gen Pract 2006; 56: 763-7.
11. IBD Working Group of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. Inflammatory bowel disease in children and adolescents: recommendations for diagnosis - the Porto criteria. J Pediatr Gastroenterol Nutr 2005; 41: 1-7.
12. Kornbluth A, Colombel JF, Leighton JA, Loftus E. ICCE consensus for inflammatory bowel disease. Endoscopy 2005; 37: 1051-4.
13. Bossuyt X. Serologic markers in inflammatory bowel disease. Clin Chem 2006; 52: 171-81.
14. Peyrin-Biroulet L, Standaert-Vitse A, Branche J, Chamaillard M. IBD serological panels: facts and perspectives. Inflamm Bowel Dis 2007; 13: 1561-6.
15. Reese GE, Constantinides VA, Simillis C, Darzi AW, Orchard TR, Fazio VW, Tekkis PP. Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Am J Gastroenterol 2006; 101: 2410-22.
16. Konikoff MR, Denson LA. Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease. Inflamm Bowel Dis 2006; 12: 524-34.
17. Fraquelli M, Colli A, Casazza G, Paggi S, Colucci A, Massironi S, Duca P, Conte D. Role of US in detection of Crohn disease: meta-analysis. Radiology 2005; 236: 95-101.
18. Horsthuis K, Bipat S, Bennink RJ, Stoker J. Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: meta-analysis of prospective studies. Radiology 2008; 247: 64-79.
19. Parente F, Greco S, Molteni M, Anderloni A, Bianchi PG. Imaging inflammatory bowel disease using bowel ultrasound. Eur J Gastroenterol Hepatol 2005; 17: 283-91.
20. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003; 3: 25.
21. Smidt N, Deeks J, Moore T (eds) (2005) Cochrane Handbook for Cochrane Reviews of Diagnostic Test Accuracy (version 0.3). The Cochrane Collaboration.
22. Zamora J, Abraira V, Muriel A, Khan KS, Coomarasamy A. Meta-Disc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 2006; 6: 31.
23. Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol 2005; 58: 982-90.
24. Gatsonis C, Paliwal P. Meta-analysis of diagnostic and screening test accuracy evaluations: methodologic primer. AJR Am J Roentgenol 2006; 187: 271-81.
25. Astegiano M, Bresso F, Cammarota T, Sarno A, Robotti D, Demarchi B, Sostegni R, Macchiarella V, Pera A, Rizzetto M. Abdominal pain and bowel dysfunction: diagnostic role of intestinal ultrasound. Eur J Gastroenterol Hepatol 2001; 13: 927-31.
26. Bellentani S, Baldoni P, Petrella S, Tata C, Armocida C, Marchegiano P, Saccoccio G, Manenti F, The Local IBS Study Group. A simple score for the identification of patients at high risk of organic diseases of the colon in the family doctor consulting room. Fam Pract 1990; 7: 307-12.
27. Bozkurt T, Richter F, Lux G. Ultrasonography as a primary diagnostic tool in patients with inflammatory disease and tumors of the small intestine and large bowel. J Clin Ultrasound 1994; 22: 85-91.
28. Brewster NT, Grieve DC, Saunders JH. Double-contrast barium enema and flexible sigmoidoscopy for routine colonic investigation. Br J Surg 1994; 81: 445-7.
29. Carroccio A, Iacono G, Cottone M et al. Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bowel syndrome: a prospective study in adults and children. Clin Chem 2003; 49: 861-7.
30. D'Inca R, Dal Pont E, Di Leo V, Ferronato A, Fries W, Vettorato MG, Martines D, Sturniolo GC. Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease. Int J Colorectal Dis 2007; 22: 429-37.
31. Dolwani S, Metzner M, Wassell JJ, Yong A, Hawthorne AB. Diagnostic accuracy of faecal calprotectin estimation in prediction of abnormal small bowel radiology. Aliment Pharmacol Ther 2004; 20: 615-21.
32. Duerr RH, Targan SR, Landers CJ, Sutherland LR, Shanahan F. Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/diarrheal illnesses. Gastroenterology 1991; 100: 1590-6.
33. Fine KD, Ogunji F, George J, Niehaus MD, Guerrant RL. Utility of a rapid fecal latex agglutination test detecting the neutrophil protein, lactoferrin, for diagnosing inflammatory causes of chronic diarrhea. Am J Gastroenterol 1998; 93: 1300-5.
34. Kaiser T, Langhorst J, Wittkowski H, Becker K, Friedrich AW, Rueffer A, Dobos GJ, Roth J, Foell D. Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome. Gut 2007; 56: 1706-13.
35. Kruis W, Thieme C, Weinzierl M, Schussler P, Holl J, Paulus W. A diagnostic score for the irritable bowel syndrome. Its value in the exclusion of organic disease. Gastroenterology 1984; 87: 1-7.
36. Otten CM, Kok L, Witteman BJ, Baumgarten R, Kampman E, Moons KG, de Wit NJ. Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome. Clin Chem Lab Med 2008; 46: 1275-80.
37. Pallotta N, Tomei E, Viscido A, Calabrese E, Marcheggiano A, Caprilli R, Corazziari E. Small intestine contrast ultrasonography: an alternative to radiology in the assessment of small bowel disease. Inflamm Bowel Dis 2005; 11: 146-53.
38. Poullis AP, Zar S, Sundaram KK, Moodie SJ, Risley P, Theodossi A, Mendall MA. A new, highly sensitive assay for C-reactive protein can aid the differentiation of inflammatory bowel disorders from constipation- and diarrhoea-predominant functional bowel disorders. Eur J Gastroenterol Hepatol 2002; 14: 409-12.
39. Schroder O, Naumann M, Shastri Y, Povse N, Stein J. Prospective evaluation of faecal neutrophil-derived proteins in identifying intestinal inflammation: combination of parameters does not improve diagnostic accuracy of calprotectin. Aliment Pharmacol Ther 2007; 26: 1035-42.
40. Sheridan MB, Nicholson DA, Martin DF. Transabdominal ultrasonography as the primary investigation in patients with suspected Crohn's disease or recurrence: a prospective study. Clin Radiol 1993; 48: 402-4.
41. Shine B, Berghouse L, Jones JE, Landon J. C-reactive protein as an aid in the differentiation of functional and inflammatory bowel disorders. Clin Chim Acta 1985; 148: 105-9.
42. Thompson WG. Gastrointestinal symptoms in the irritable bowel compared with peptic ulcer and inflammatory bowel disease. Gut 1984; 25: 1089-92.
43. Tibble J, Teahon K, Thjodleifsson B, Roseth A, Sigthorsson G, Bridger S, Foster R, Sherwood R, Fagerhol M, Bjarnason I. A simple method for assessing intestinal inflammation in Crohn's disease. Gut 2000; 47: 506-13.
44. Wassell J, Dolwani S, Metzner M, Losty H, Hawthorne A. Faecal calprotectin: a new marker for Crohn's disease? Ann Clin Biochem 2004; 41: 230-2.
45. Whitehead WE, Palsson OS, Feld AD, Levy RL, Von Korff M, Turner MJ, Drossman DA. Utility of red flag symptom exclusions in the diagnosis of irritable bowel syndrome. Aliment Pharmacol Ther 2006; 24: 137-46.
46. Chalubinski K, Brunner H. Positive diagnosis of irritable colon: a scored chart or standardized anamnesis? Wien Klin Wochenschr 1987; 99: 819-24.
47. Limburg PJ, Ahlquist DA, Sandborn WJ, Mahoney DW, Devens ME, Harrington JJ, Zinsmeister AR. Fecal calprotectin levels predict colorectal inflammation among patients with chronic diarrhea referred for colonoscopy. Am J Gastroenterol 2000; 95: 2831-7.
48. Metcalf JV, Smith J, Jones R, Record CO. Incidence and causes of rectal bleeding in general practice as detected by colonoscopy. Br J Gen Pract 1996; 46: 161-4.
49. Higgins JP, Thompson SG. Controlling the risk of spurious findings from meta-regression. Stat Med 2004; 23: 1663-82.
50. Nielsen OH, Vainer B, Madsen SM, Seidelin JB, Heegaard NH. Established and emerging biological activity markers of inflammatory bowel disease. Am J Gastroenterol 2000; 95: 359-67.
51. Parente F, Greco S, Molteni M, Anderloni A, Maconi G, Bianchi PG. Modern imaging of Crohn's disease using bowel ultrasound. Inflamm Bowel Dis 2004; 10: 452-61.
52. Smidt N, Rutjes AW, van der Windt DA, Ostelo RW, Reitsma JB, Bossuyt PM, Bouter LM, de Vet HCW. Quality of reporting of diagnostic accuracy studies. Radiology 2005; 235: 347-53.
53. Whiting P, Rutjes AW, Reitsma JB, Glas AS, Bossuyt PM, Kleijnen J. Sources of variation and bias in studies of diagnostic accuracy: a systematic review. Ann Intern Med 2004; 140: 189-202.